Skip to main content

Advertisement

Log in

Genetic association between IL23R rs11209026 and rs10889677 polymorphisms and risk of Crohn’s disease and ulcerative colitis: evidence from 41 studies

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objective

IL23R plays an important role in the pathogenesis of inflammatory bowel disease (IBD). The IL23R rs11209026 and rs10889677 polymorphisms have been shown to be associated with the development of Crohn’s disease (CD) and ulcerative colitis (UC). But the results were inconsistent and inconclusive. So, we aim to investigate the genetic association between rs11209026 and rs10889677 polymorphisms and UC and CD risk by a meta-analysis.

Methods

Literature search was conducted through PubMed, CNKI, and web of science databases. Pooled OR and 95% CI was used to assess the association between the allelic, dominant and recessive models of IL23R rs11209026 and rs10889677 polymorphisms and UC and CD risk.

Results

41 publications with 13,803 patients with CD and 17,446 controls, as well as 5876 patients with UC and 10,053 controls were included in the present study. All the genetic models of rs11209026 polymorphism significantly decrease CD and UC risk (except for the recessive model in UC) (p < 0.05). A subgroup analysis based on ethnicity showed that the allelic (p < 0.00001, OR = 0.65) and dominant models (p < 0.00001, OR = 0.61) of rs11209026 polymorphism were significantly associated with UC risk in Caucasians, but not in Asians (p > 0.05). In addition, the allelic (CD: p < 0.00001, OR = 1.34; UC: p < 0.00001, OR = 1.22) and dominant models (CD: p = 0.002, OR = 1.39; UC: p = 0.01, OR = 1.29), but not the recessive model of rs10889677 polymorphism significantly increase the risk of CD and UC (p > 0.05). A subgroup analysis showed that the genetic models of rs10889677 polymorphism were associated with CD risk in Caucasians (p < 0.05), but not in Asians (p > 0.05). The dominant model of rs10889677 polymorphism was associated with UC risk in Asians (p = 0.04, OR = 1.54), but not in Caucasians (p > 0.05).

Conclusions

Our meta-analysis demonstrated that the rs11209026 polymorphism might be a protective factor against developing IBD, while the rs10889677 polymorphism might be a risk factor for IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1 A
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Kim DH, Cheon JH. Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune Netw. 2017;17(1):25–40.

    PubMed  PubMed Central  Google Scholar 

  2. Abraham BP, Ahmed T, Ali T. Inflammatory bowel disease: pathophysiology and current therapeutic approaches. Handb Exp Pharmacol. 2017;239:115.

    CAS  PubMed  Google Scholar 

  3. Weingarden AR, Vaughn BP. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes. 2017;8(3):238.

    PubMed  PubMed Central  Google Scholar 

  4. Bernstein CN. Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology. Aliment Pharmacol Ther. 2017;46(10):911–9.

    CAS  PubMed  Google Scholar 

  5. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3(7):390–407.

    CAS  PubMed  Google Scholar 

  6. Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol. 2010;106(3):323–30.

    Google Scholar 

  7. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet. 2002;359(9318):1661–5.

    CAS  PubMed  Google Scholar 

  8. de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet. 2017;49(2):256–61.

    PubMed  PubMed Central  Google Scholar 

  9. Yamazaki K, Umeno J, Takahashi A, Hirano A, Johnson TA, Kumasaka N, et al. A genome-wide association study identifies 2 susceptibility loci for Crohn's disease in a Japanese population. Gastroenterology. 2013;144(4):781–8.

    CAS  PubMed  Google Scholar 

  10. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than thirty distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40(8):955–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Fisher SA, Hampe J, Onnie CM, Daly MJ, Curley C, Purcell S, et al. Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease. Hum Mutat. 2010;27(8):778–85.

    Google Scholar 

  12. Shafieyoun A, Moraveji S, Bashashati M, Rezaei N. Discs large homolog 5 (DLG5) gene polymorphism and Crohn's disease: a meta-analysis of the published studies. Acta Med Iran. 2016;54(5):289–95.

    PubMed  Google Scholar 

  13. Urcelay E, Mendoza JL, Martín MC, Mas A, Martínez A, Taxonera C, et al. MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis. 2010;12(1):33–7.

    Google Scholar 

  14. Lamia K, Samira M, Monia F, Serghimi M, Fekih M, Matri S, et al. Toll-like receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn's disease: genotype-phenotype correlation. Bmc Gastroenterology. 2009;9(1):62.

    Google Scholar 

  15. Yang DH, Yang SK, Song K, Hong M, Park SH, Lee HS, et al. TNFSF15 is an independent predictor for the development of Crohn's disease-related complications in Koreans. J Crohns Colitis. 2014;8(10):1315–26.

    PubMed  Google Scholar 

  16. Kaser A, Blumberg RS. ATG16L1 Crohn's disease risk stresses the endoplasmic reticulum of Paneth cells. Gut. 2014;63(7):1038–9.

    CAS  PubMed  Google Scholar 

  17. Abraham C, Cho JH. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2008;60(60):97–110.

    Google Scholar 

  18. Di MP, Di CA, Laggner U, Chu CC, Napolitano L, Villanova F, et al. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS ONE ONE. 2011;6(2):e17160.

    Google Scholar 

  19. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314(5804):1461–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Hayatbakhsh MM, Zahedi MJ, Shafiepour M, Nikpoor AR, Mohammadi M. IL-23 receptor gene rs7517847 and rs1004819 SNPs in ulcerative colitis. Iran J Immunol. 2012;9(2):128–35.

    CAS  PubMed  Google Scholar 

  21. Sarlos P, Varszegi D, Csongei V, Magyari L, Jaromi L, Nagy L, et al. Susceptibility to ulcerative colitis in Hungarian patients determined by gene-gene interactions. World J Gastroenterol. 2014;20(1):219–27.

    PubMed  PubMed Central  Google Scholar 

  22. Amre DK, Mack D, Israel D, Morgan K, Lambrette P, Law L, et al. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children. Am J Gastroenterol. 2008;103(3):615–20.

    CAS  PubMed  Google Scholar 

  23. Baldassano RN, Bradfield JP, Monos DS, Kim CE, Glessner JT, Casalunovo T, et al. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn’s disease. Clin Gastroenterol Hepatol. 2007;5(8):972–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Baptista ML, Amarante H, Picheth G, Sdepanian VL, Peterson N, Babasukumar U, et al. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population. Inflamm Bowel Dis. 2010;14(5):674–9.

    Google Scholar 

  25. Borgiani P, Perricone C, Ciccacci C, Romano S, Novelli G, Biancone L, et al. Interleukin-23R Arg381Gln is associated with susceptibility to Crohn’s disease but not with phenotype in an Italian population. Gastroenterology. 2007;133(3):1049–51.

    CAS  PubMed  Google Scholar 

  26. Buning C, Schmidt HH, Molnar T, De Jong DJ, Fiedler T, Bühner S, et al. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment Pharmacol Ther. 2010;26(7):1025–33.

    Google Scholar 

  27. Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, Morgan AR. IL23R and IL12B SNPs and haplotypes strongly associate with Crohn's disease risk in a New Zealand population. Gastroenterol Res Pract. 2010;2010(2010):539461.

    PubMed  PubMed Central  Google Scholar 

  28. Oliver J, Rueda B, López-Nevot MA, Gómez-García M, Martín J, et al. (2007) Replication of an Association Between IL23R Gene Polymorphism with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 5(8), 977–81, 981.e1–2.

    Google Scholar 

  29. Kanaan Z, Ahmad S, Roberts H, Thé T, Girdler S, Pan J, et al. Crohn’s disease in Caucasians and African Americans, as defined by clinical predictors and single nucleotide polymorphisms. J Natl Med Assoc. 2012;104(9–10):420–7.

    PubMed  Google Scholar 

  30. Lauriola M, Ugolini G, Rivetti S, Nanì S, Rosati G, Zanotti S, et al. IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn’s disease and correlation with sub-phenotypes. Int J Mol Med. 2011;27(3):469–77.

    PubMed  Google Scholar 

  31. Najmi Varzandeh F, Farhadi E, Ebrahimi Daryani N, Taher M, Mahmoudi M, Bashashati M, et al. Interleukin-23 receptor single nucleotide polymorphisms in Crohn’s disease. Clin Res Hepatol Gastroenterol. 2015;39(4):e51–e5353.

    CAS  PubMed  Google Scholar 

  32. Cotterill L, Payne D, Levinson S, McLaughlin J, Wesley E, Feeney M, et al. Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn’s disease. Can J Gastroenterol. 2010;24(5):297–302.

    PubMed  PubMed Central  Google Scholar 

  33. Cummings J, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L, et al. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm Bowel Dis. 2010;13(9):1063–8.

    Google Scholar 

  34. Glas J, Seiderer J, Wetzke M, Konrad A, Török HP, Schmechel S, et al. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS ONE ONE. 2007;2(9):e819.

    Google Scholar 

  35. Lakatos PL, Szamosi T, Szilvasi A, Molnar E, Lakatos L, Kovacs A, et al. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Dig Liver Dis. 2008;40(11):867–73.

    CAS  PubMed  Google Scholar 

  36. Lappalainen M, Halme L, Turunen U, Saavalainen P, Einarsdottir E, Färkkilä M, et al. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflamm Bowel Dis. 2008;14(8):1118–24.

    PubMed  Google Scholar 

  37. Latiano A, Palmieri O, Valvano MR, D'Incà R, Cucchiara S, Riegler G, et al. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult-and pediatric-onset inflammatory bowel disease in Italy. World J Gastroenterol. 2008;14(29):4643–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Lu ZK, Chen ZR, Zhu JY, Xu Y, Hua X. Analysis of the association of single nucleotide polymorphisms of interleukin-23 receptor (IL-23R) and inflammatory bowel disease in a Chinese Han cohort. Oncotarget. 2016;7(42):67851–6.

    PubMed  PubMed Central  Google Scholar 

  39. Márquez A, Mendoza JL, Taxonera C, Díaz-Rubio M, De La Concha EG, Urcelay E, et al. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis. 2010;14(9):1192–6.

    Google Scholar 

  40. Mihaljević S, Kibel A, Stefanić M, Glavas-Obrovac L, Takac B, Krznarić Z, et al. Polymorphisms of interleukin-23 receptor in patients with inflammatory bowel disease in a Croatian tertiary center. Coll Antropol. 2013;37(4):1171–7.

    PubMed  Google Scholar 

  41. Okazaki T, Wang M, Rawsthorne P, Sargent M, Datta LW, Shugart YY, et al. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene–gene interactions. Inflamm Bowel Dis. 2012;18(8):1528–41.

    Google Scholar 

  42. Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V, et al. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn’s disease in a study of new Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol. 2007;102(12):2754–61.

    CAS  PubMed  Google Scholar 

  43. Sventoraityte J, Zvirbliene A, Franke A, Kwiatkowski R, Kiudelis G, Kupcinskas L, et al. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease. World J Gastroenterol. 2010;16(3):359.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A, et al. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology. 2007;132(5):1657–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Van Limbergen J, Russell RK, Nimmo ER, Drummond HE, Smith L, Davies G, et al. IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut. 2007;56(8):1173–4.

    PubMed  PubMed Central  Google Scholar 

  46. Venegas M, Beltrán CJ, Alvarez L, Castro A, Torres T, Leal AD, et al. IL-23R Arg381Gln polymorphism in Chilean patients with inflammatory bowel disease. Eur Cytokine Netw. 2008;19(4):190–5.

    CAS  PubMed  Google Scholar 

  47. Weersma RK, Zhernakova A, Nolte IM, Lefebvre C, Rioux JD, Mulder F, et al. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Am J Gastroenterol. 2008;103(3):621.

    CAS  PubMed  Google Scholar 

  48. Safrany E, Szabo M, Szell M, Kemeny L, Sumegi K, Melegh BI, et al. Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn’s disease and psoriasis. Inflamm Res. 2013;62(2):195–200.

    CAS  PubMed  Google Scholar 

  49. Civitavecchia G, Renda MC, Ruggeri RF, Maggio A, Renna S, Orlando A, et al. IL-23R determines susceptibility in Crohn’s disease in a Mediterranean area. Inflamm Bowel Dis. 2009;15(2):317–8.

    CAS  PubMed  Google Scholar 

  50. Dusatkova P, Hradsky O, Lenicek M, Bronsky J, Nevoral J, Kotalova R, et al. Association of IL23R p.381Gln and ATG16L1 p.197Ala with Crohn disease in the Czech population. J Pediatr Gastroenterol Nutr. 2009;49(4):405–10.

    CAS  PubMed  Google Scholar 

  51. Gaj P, Habior A, Mikula M, Ostrowski J. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. BMC Med Genet. 2008;9:81.

    PubMed  PubMed Central  Google Scholar 

  52. Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Chrousos G, Anagnou NP, et al. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn’s disease. World J Gastroenterol. 2010;16(14):1753–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Leshinsky-Silver E, Karban A, Dalal I, Eliakim R, Shirin H, Tzofi T, et al. Evaluation of the interleukin-23 receptor gene coding variant R381Q in pediatric and adult Crohn disease. J Pediatr Gastroenterol Nutr. 2007;45(4):405–8.

    PubMed  Google Scholar 

  54. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, Franchimont D, et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 2007;3(4):e57.

    Google Scholar 

  55. Momozawa Y, Mni M, Nakamura K, Coppieters W, Almer S, Amininejad L, et al. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet. 2011;43(1):43–7.

    CAS  PubMed  Google Scholar 

  56. Yang SK, Park M, Lim J, Park SH, Ye BD, Lee I, et al. Contribution of IL23R but Not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflamm Bowel Dis. 2009;15(9):1385–90.

    PubMed  Google Scholar 

  57. Zhang J, Chen J, Gu J, Guo H, Chen W. Association of IL23R and ATG16L1 with susceptibility of Crohn’s disease in Chinese population. Scand J Gastroenterol. 2014;49(10):1201–6.

    CAS  PubMed  Google Scholar 

  58. Daryani NE, Varzaneh FN, Rezaei N. Association of interleukin-23 receptor single nucleotide polymorphisms with ulcerative colitis. J Allergy Clin Immunol. 2014;133(2):AB184.

    Google Scholar 

  59. Szabo M, Safrany E, Pazar B, Melegh BI, Kisfali P, Poor G, et al. Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn’s disease and ankylosing spondylitis. Mol Biol Rep. 2013;40(1):359–63.

    CAS  PubMed  Google Scholar 

  60. Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn’s disease in Japanese patients. J Hum Genet. 2007;52:575–83.

    CAS  PubMed  Google Scholar 

  61. Cui M, Tan F, Wang HK, Yao P, Tan QH. Gene polymorphisms of interleukin-23 receptor in Uygur and Han Chinese patients with ulcerative colitis. World Chin J Digestol. 2017;25(23):2109.

    Google Scholar 

  62. Liu Z, Yadav PK, Xu X, Su J, Chen C, Tang M, et al. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol. 2011;89(4):597.

    CAS  PubMed  Google Scholar 

  63. Cui Y, Huang ZG, Liu ZJ. Immunoregulatory effects of IL-23 on inflammatory bowel disease. World Chin J Digestol. 2009;17(16):1649–54.

    CAS  Google Scholar 

  64. Can G, Tezel A, Gürkan H, Tozkır H, Ünsal G, Soylu AR, et al. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population. Turk J Gastroenterol. 2016;27(6):525–36.

    PubMed  Google Scholar 

  65. Davidson SI, Wu X, Liu Y, Wei M, Danoy PA, Thomas G, et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 2014;60(11):3263–8.

    Google Scholar 

  66. Orozco G, Rueda B, Robledo G, García A, Martín J, et al. Investigation of the IL23R gene in a Spanish rheumatoid arthritis cohort. Hum Immunol. 2007;68(8):681–4.

    CAS  PubMed  Google Scholar 

  67. Kim ES, Kim SW, Chang MM, Park JJ, Kim TI, Kim WH, et al. Interactions between IL17A, IL23R, and STAT4 polymorphisms confer susceptibility to intestinal Behcet's disease in Korean population. Life Sci. 2012;90(19–20):740–6.

    CAS  PubMed  Google Scholar 

  68. Sánchez E, Rueda B, Callejas JL, Sabio JM, Ortego-Centeno N, Jimenez-Alonso J, et al. Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus. Tissue Antigens. 2010;70(3):233–7.

    Google Scholar 

  69. Pidasheva S, Trifari S, Phillips A, Hackney JA, Ma Y, Smith A, et al. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS ONE ONE. 2011;6(10):e25038.

    CAS  Google Scholar 

  70. Conte MP, Schippa S, Zamboni I, Penta M, Chiarini F, Seganti L, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut. 2006;55(12):1760–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  71. Li Y, Mao Q, Shen L, Tian Y, Yu C, Zhu WM, et al. Interleukin-23 receptor genetic polymorphisms and Crohn’s disease susceptibility: a meta-analysis. Inflamm Res. 2010;59:607–14.

    CAS  PubMed  Google Scholar 

  72. Liu M, Zhu W, Wang J, Zhang J, Guo X, Wang J, et al. Interleukin-23 receptor genetic polymorphisms and ulcerative colitis susceptibility: a meta-analysis. Clin Res Hepatol Gastroenterol. 2015;39(4):516–25.

    CAS  PubMed  Google Scholar 

  73. Ni B, Chen S, Xie H, Ma H. Functional polymorphisms in interleukin-23 receptor and susceptibility to esophageal squamous cell carcinoma in Chinese population. PLoS ONE ONE. 2014;9(2):e89111.

    Google Scholar 

Download references

Acknowledgements

This study was funded by the Medical and Health Science and Technology Project of Zhejiang Province, China (2019KY214); Jiaxing Key Discipiline of Medcine—Oncology (Supporting Subject) 2019-zc-11; The Basic Public Welfare Research Program of Zhejiang Province, China (LGF18H160033); The Medical and Health Science and Technology Project of Zhejiang Province, China (2019KY692); Project of Public Welfare research of Jiaxing (2019AD32257).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yi Zhu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Responsible Editor: Dr. John Di Battista.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 32 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, Y., Jiang, H., Chen, Z. et al. Genetic association between IL23R rs11209026 and rs10889677 polymorphisms and risk of Crohn’s disease and ulcerative colitis: evidence from 41 studies. Inflamm. Res. 69, 87–103 (2020). https://doi.org/10.1007/s00011-019-01296-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-019-01296-y

Keywords

Navigation